Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform.
- DOI
- 10.1073/pnas.2313681121
- Published
- 2024 Mar 5
- Container
- Proceedings of the National Academy of Sciences of the United States of America
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1073/pnas.2313681121,
title = {Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform.},
author = {Chang S and Shin KS and Park B and Park S and Shin J and Park H and Jung IK and Kim JH and Bae SE and Kim JO and Baek SH and Kim G and Hong JJ and Seo H and Volz E and Kang CY},
year = {2024},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
doi = {10.1073/pnas.2313681121},
url = {https://doi.org/10.1073/pnas.2313681121}
}RIS
TY - JOUR TI - Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform. AU - Chang S AU - Shin KS AU - Park B AU - Park S AU - Shin J AU - Park H AU - Jung IK AU - Kim JH AU - Bae SE AU - Kim JO AU - Baek SH AU - Kim G AU - Hong JJ AU - Seo H AU - Volz E AU - Kang CY PY - 2024 JO - Proceedings of the National Academy of Sciences of the United States of America DO - 10.1073/pnas.2313681121 UR - https://doi.org/10.1073/pnas.2313681121 ER -
APA
S, C., KS, S., B, P., S, P., J, S., H, P., IK, J., JH, K., SE, B., JO, K., SH, B., G, K., JJ, H., H, S., E, V., & CY, K. (2024). Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform.. Proceedings of the National Academy of Sciences of the United States of America. https://doi.org/10.1073/pnas.2313681121
Source records
- pubmed · retrieved 2026-09-26T16:43:03.910Z